Anlon Healthcare Limited has successfully completed the acquisition of a 63.98% (Sixty Three Point Nine Eight percent) equity shareholding in Remember India Health Links Private Limited on May 8, 2026. This milestone follows the execution of a Share Purchase Agreement (SPA) dated April 16, 2026, and was disclosed to the stock exchanges pursuant to Regulation 30(7) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Acquisition Details

The completion of this acquisition marks a significant corporate development for Anlon Healthcare. Consequent to the transaction, Remember India Health Links Private Limited has become a subsidiary of Anlon Healthcare Limited. The key details of the acquisition are summarised below:

Regulatory Compliance

The acquisition has been carried out in compliance with Section 179(3)(e) and (j) and all other applicable provisions of the Companies Act, 2013. The disclosure was made under Regulation 30(7) read with Para A of Part A of Schedule III of the SEBI Listing Regulations, and in continuation of the earlier intimation dated April 16, 2026. Additional details, as required under the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, were provided in the earlier disclosure dated April 16, 2026.

The disclosure was signed by Punitkumar Rasadia, Managing Director of Anlon Healthcare Limited (DIN: 06696258), on May 8, 2026.

Anlon Healthcare Limited has filed its annual disclosure under Regulation 30(1), 30(2), and Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the financial year 2025-2026. The disclosure, dated April 01, 2026, was submitted to the listing departments of both BSE Limited and the National Stock Exchange of India Ltd. It was signed by Punitkumar Rasadia, Managing Director (DIN: 06696258), on behalf of all promoters of the company.

Key Declaration by Promoters

In the disclosure, the promoters and members of the promoter group formally declared that no encumbrance — direct or indirect — was created on shares of Anlon Healthcare Limited at any point during the financial year 2025-2026. This declaration is in compliance with the requirements set out under Regulation 31(4) of the SEBI Takeover Regulations, 2011, as amended.

Promoter and Promoter Group Members

The disclosure includes an Annexure listing all individuals and entities belonging to the promoter and promoter group of the company. The following table presents the complete list as submitted:

Filing Details

The disclosure was submitted to the stock exchanges in accordance with regulatory requirements. Key details of the filing are summarised below:

The filing confirms that all promoters and promoter group members of Anlon Healthcare Limited are in compliance with the annual disclosure requirements prescribed by SEBI under the Takeover Regulations for the financial year 2025-2026.